Bortezomib-Associated Optic Atrophy in Two Patients With Multiple Myeloma

Update Item Information
Title Bortezomib-Associated Optic Atrophy in Two Patients With Multiple Myeloma
Creator Joseph G. Chacko, MD; Raed Behbehani, MD; Kelsey N. Hundley, MD; Yazan Al-Fanek, BS
Affiliation Department of Ophthalmology (JGC, KNH, YA-F), Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas; and Department of Ophthalmology (RB), Al-Bahar Eye Center, Sabah Medical Area, Kuwait City, Kuwait
Subject Antineoplastic Agents / adverse effects; Antineoplastic Agents / therapeutic use; Bortezomib / adverse effects; Bortezomib / therapeutic use; Female; Humans; Male; Middle Aged; Multiple Myeloma / drug therapy; Optic Atrophy / chemically induced; Optic Atrophy / diagnosis; Optic Disk / pathology; Tomography, Optical Coherence / methods; Visual Acuity
OCR Text Show
Date 2018-12
Language eng
Format application/pdf
Type Text
Publication Type Journal Article
Source Journal of Neuro-Ophthalmology, December 2018, Volume 38, Issue 4
Collection Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management © North American Neuro-Ophthalmology Society
ARK ark:/87278/s6ff8t8k
Setname ehsl_novel_jno
ID 1500760
Reference URL https://collections.lib.utah.edu/ark:/87278/s6ff8t8k
Back to Search Results